Blueprint Medicines Statistics
Total Valuation
NEO:TXN has a market cap or net worth of CAD 228.93 billion. The enterprise value is 240.90 billion.
Market Cap | 228.93B |
Enterprise Value | 240.90B |
Important Dates
The last earnings date was Monday, July 21, 2025.
Earnings Date | Jul 21, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Current Share Class | n/a |
Shares Outstanding | n/a |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | -0.44% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 906.86M |
Valuation Ratios
The trailing PE ratio is 33.47 and the forward PE ratio is 29.71.
PE Ratio | 33.47 |
Forward PE | 29.71 |
PS Ratio | 10.07 |
PB Ratio | 10.23 |
P/TBV Ratio | 14.23 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 22.83, with an EV/FCF ratio of 117.52.
EV / Earnings | 35.22 |
EV / Sales | 10.48 |
EV / EBITDA | 22.83 |
EV / EBIT | 30.01 |
EV / FCF | 117.52 |
Financial Position
The company has a current ratio of 5.81, with a Debt / Equity ratio of 0.86.
Current Ratio | 5.81 |
Quick Ratio | 3.74 |
Debt / Equity | 0.86 |
Debt / EBITDA | 1.83 |
Debt / FCF | 9.34 |
Interest Coverage | 11.16 |
Financial Efficiency
Return on equity (ROE) is 29.99% and return on invested capital (ROIC) is 11.83%.
Return on Equity (ROE) | 29.99% |
Return on Assets (ROA) | 10.41% |
Return on Invested Capital (ROIC) | 11.83% |
Return on Capital Employed (ROCE) | 17.96% |
Revenue Per Employee | 668,893 |
Profits Per Employee | 201,169 |
Employee Count | 34,000 |
Asset Turnover | 0.48 |
Inventory Turnover | 1.57 |
Taxes
In the past 12 months, NEO:TXN has paid 853.78 million in taxes.
Income Tax | 853.78M |
Effective Tax Rate | 11.05% |
Stock Price Statistics
Beta (5Y) | n/a |
52-Week Price Change | n/a |
50-Day Moving Average | 21.38 |
200-Day Moving Average | 20.44 |
Relative Strength Index (RSI) | 29.42 |
Average Volume (20 Days) | 10,247 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | 2.45 |
Income Statement
In the last 12 months, NEO:TXN had revenue of CAD 22.74 billion and earned 6.84 billion in profits. Earnings per share was 7.46.
Revenue | 22.74B |
Gross Profit | 13.20B |
Operating Income | 7.95B |
Pretax Income | 7.73B |
Net Income | 6.84B |
EBITDA | 10.24B |
EBIT | 7.95B |
Earnings Per Share (EPS) | 7.46 |
Balance Sheet
The company has 7.31 billion in cash and 19.15 billion in debt, giving a net cash position of -11.84 billion.
Cash & Cash Equivalents | 7.31B |
Total Debt | 19.15B |
Net Cash | -11.84B |
Net Cash Per Share | n/a |
Equity (Book Value) | 22.37B |
Book Value Per Share | 24.61 |
Working Capital | 16.36B |
Cash Flow
In the last 12 months, operating cash flow was 8.78 billion and capital expenditures -6.73 billion, giving a free cash flow of 2.05 billion.
Operating Cash Flow | 8.78B |
Capital Expenditures | -6.73B |
Free Cash Flow | 2.05B |
FCF Per Share | n/a |
Margins
Gross margin is 58.03%, with operating and profit margins of 34.94% and 30.23%.
Gross Margin | 58.03% |
Operating Margin | 34.94% |
Pretax Margin | 33.99% |
Profit Margin | 30.23% |
EBITDA Margin | 45.03% |
EBIT Margin | 34.94% |
FCF Margin | 9.01% |
Dividends & Yields
NEO:TXN does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | 97.20% |
Buyback Yield | -0.11% |
Shareholder Yield | n/a |
Earnings Yield | 2.99% |
FCF Yield | 0.90% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | |
Lynch Upside | |
Graham Number | |
Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
NEO:TXN has an Altman Z-Score of 9.19 and a Piotroski F-Score of 5.
Altman Z-Score | 9.19 |
Piotroski F-Score | 5 |